Cell Growth & Differentiation, Vol 2, Issue 1 33-41, Copyright © 1991 by American Association of Cancer Research

ARTICLES

Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells

D Resnitzky and A Kimchi
Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.

The proliferation of M1 myeloblastic cells can be specifically restricted at the G0/G1 phase of the cell cycle by exposure to alpha- and beta-interferons or to interleukin 6. The latter cytokine also induces the morphological and functional differentiation of these myeloblasts toward monocytes. Each of these two different cytokines suppresses the expression of the c-myc nuclear oncogene, and the selective reduction in c-myc mRNA and protein precedes the cell cycle changes. In order to investigate whether one or more of the growth-suppressive effects of interferon and interleukin 6 are mediated by c-myc reduction, M1 cells were transfected with SV40-driven c-myc plasmid, whose expression fails to be turned off by these two cytokines. A detailed analysis of the responses to interferon and to interleukin 6 revealed that all of the myc-transfected clones have lost the cytokine-mediated G0/G1 type of growth arrest. However, not all of the growth responses to these cytokines were rescued by this specific genetic manipulation, and the cytokine-treated transfected cells stopped to proliferate in a new fashion which was not cell cycle specific. In addition, the myc-transfected cells developed the differentiated phenotype in response to interleukin 6, as determined by the morphological change, expression of Fc receptors, and cytochemical analysis, suggesting that these molecular events can occur in the monocyte cell lineage in spite of the abnormal constitutive expression of c-myc.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				P N Tulley, M Neale, D Jackson, J S Chana, R Grover, I Cree, A O Grobbelaar, and G D Wilson The relation between c-myc expression and interferon sensitivity in uveal melanoma Br. J. Ophthalmol., December 1, 2004; 88(12): 1563 - 1567. [Abstract] [Full Text] [PDF]

				P. Geserick, F. Kaiser, U. Klemm, S. H. E. Kaufmann, and J. Zerrahn Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif Int. Immunol., October 1, 2004; 16(10): 1535 - 1548. [Abstract] [Full Text] [PDF]

				T. Raveh, A. G. Hovanessian, E. F. Meurs, N. Sonenberg, and A. Kimchi Double-stranded RNA-dependent Protein Kinase Mediates c-Myc Suppression Induced by Type I Interferons J. Biol. Chem., October 11, 1996; 271(41): 25479 - 25484. [Abstract] [Full Text] [PDF]

				L P Deiss, E Feinstein, H Berissi, O Cohen, and A Kimchi Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes & Dev., January 1, 1995; 9(1): 15 - 30. [Abstract] [PDF]

				L. Deiss and A Kimchi A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal Science, April 5, 1991; 252(5002): 117 - 120. [Abstract] [PDF]